Forbes January 20, 2026
William A. Haseltine

Genetic variants can act together, inhibit one another or trigger a whole chain of events, making the genetic puzzle far more complex than single-gene models suggest. New research has found that two genetic mutations, each individually harmful, can sometimes combine to restore normal protein function. This is just one example of a broader phenomenon: no gene acts alone. Rather, our health is shaped by a vast puzzle of interacting genes and genetic variants.

Sometimes genes work together, sometimes they inhibit each other and often, a whole chain of events must unfold before a genetic predisposition manifests. That’s why no single gene is fully dominant, and why our understanding of genetic risk must consider the many factors at play. This concept...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma / Biotech
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat
Biotech investor Cormorant secures $150M for another SPAC deal
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety
Introducing the Sunday Times Tech 100: Life sciences part 1
China’s edge in early-stage drugmaking ‘likely to persist,’ Pitchbook says

Share Article